Home »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 3, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today provided an update on the clinical development and production of mRNA-1273, its vaccine candidate against COVID-19. Interim Durability Data from NIH-led Phase 1 Study of mRNA-1273 Today, […]
A group of researchers at Neuromod Devices Limited, working with an international team of researchers, reports positive results in a clinical trial set up to test a non-invasive stimulation device to treat tinnitus. In their paper published in the journal Science Translational Medicine, the group describes the science behind the device and how well it […]
MONDAY, Sept. 28, 2020 — Vitamin D sufficiency is associated with reduced clinical severity, inpatient mortality, and serum levels of C-reactive protein (CRP) among patients infected with COVID-19, according to a study published online Sept. 25 in PLOS ONE. Zhila Maghbooli, Ph.D., from the Tehran University of Medical Sciences in Iran, and colleagues analyzed hospital […]
London, UK and Paris, France 03 September 2020 — Sanofi and GSK announce today the start of the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines with GSK’s established pandemic adjuvant […]
An expert panel convened at Tuesday’s Teladoc-sponsored Telehealth Innovation Forum predicted changes to the originating and geographic site requirements for telehealth – but not to state licensure waivers allowing physicians from one state to practice in another. Although licensure waivers have been of particular importance during the COVID-19 pandemic, Claudia Duck Tucker, vice president of […]
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma—taken from people who have recovered from COVID-19—is effective in treating the disease. The body’s immune response to viral infections includes making molecules called antibodies. Antibodies can combat the infection and possibly prevent reinfection […]
Non-small cell lung cancer (NSCLC) patients with higher measures of tumor mutations that show up in a blood test generally have a better clinical response to PD-1-based immunotherapy treatments than patients with a lower measure of mutations. A clinical trial led by researchers from the Perelman School of Medicine at the University of Pennsylvania and […]
A new cancer clinical trial has opened at the M Health Fairview University of Minnesota Medical Center that leverages the groundbreaking research on stem cells and natural killer (NK) cells done at the Masonic Cancer Center and applies it to attack acute myeloid leukemia (AML) and B-cell lymphoma. The first-of-its-kind NK cell cancer immunotherapy, called […]
Francisco Partners, an IT-focused private equity firm says it plans to acquire Orchard Software, the laboratory information systems vendor. WHY IT MATTERS Orchard’s LIS technology, along with other clinical and pathology laboratory workflow tools and lab outreach and point-of-care testing products will benefit from the deal, said Francisco Partners Principal Jonathan Murphy. With the acquisition, […]
Jehangir Hospital, a 350-bed hospital in Pune, India, along with its research arm Jehangir Clinical Development Centre (JCDC), last week announced that it will join Clinerion’s Patient Network Explorer platform. Clinerion is a global data technology service company headquartered in Switzerland while JCDC has over 60 principal investigators and conducts on average 25-30 clinical studies […]